- Home
- MIRM vs UUUU Comparison
MIRM vs UUUU Comparison
Compare MIRM & UUUU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIRM
- UUUU
- Stock Information
- Founded
- MIRM 2018
- UUUU 1987
- Country
- MIRM United States
- UUUU United States
- Employees
- MIRM N/A
- UUUU N/A
- Industry
- MIRM Biotechnology: Pharmaceutical Preparations
- UUUU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- MIRM Health Care
- UUUU Industrials
- Exchange
- MIRM Nasdaq
- UUUU Nasdaq
- Market Cap
- MIRM 3.3B
- UUUU 2.7B
- IPO Year
- MIRM 2019
- UUUU N/A
- Fundamental
- Price
- MIRM $73.14
- UUUU $14.08
- Analyst Decision
- MIRM Strong Buy
- UUUU Strong Buy
- Analyst Count
- MIRM 10
- UUUU 4
- Target Price
- MIRM $74.20
- UUUU $10.38
- AVG Volume (30 Days)
- MIRM 679.0K
- UUUU 14.4M
- Earning Date
- MIRM 11-11-2025
- UUUU 10-30-2025
- Dividend Yield
- MIRM N/A
- UUUU N/A
- EPS Growth
- MIRM N/A
- UUUU N/A
- EPS
- MIRM N/A
- UUUU N/A
- Revenue
- MIRM $429,161,000.00
- UUUU $65,078,999.00
- Revenue This Year
- MIRM $53.08
- UUUU N/A
- Revenue Next Year
- MIRM $20.45
- UUUU $146.66
- P/E Ratio
- MIRM N/A
- UUUU N/A
- Revenue Growth
- MIRM 62.33
- UUUU 42.73
- 52 Week Low
- MIRM $36.86
- UUUU $3.20
- 52 Week High
- MIRM $78.10
- UUUU $14.41
- Technical
- Relative Strength Index (RSI)
- MIRM 58.57
- UUUU 68.20
- Support Level
- MIRM $73.35
- UUUU $11.82
- Resistance Level
- MIRM $74.99
- UUUU $14.41
- Average True Range (ATR)
- MIRM 2.37
- UUUU 0.91
- MACD
- MIRM -0.94
- UUUU 0.14
- Stochastic Oscillator
- MIRM 20.40
- UUUU 91.09
About MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.
About UUUU Energy Fuels Inc (Canada)
Energy Fuels Inc is a United States-based critical minerals company. The Company mines uranium and produces natural uranium concentrates that are sold to nuclear utilities for the production of carbon-free nuclear energy. It holds two of America's key uranium production centers: The White Mesa Mill in Utah, and the Nichols Ranch ISR Facility in Wyoming. It has three reportable segments based on its operations and financial information; Uranium, HMS, and REE.